Sen. Ron Johnson convened medical experts on Capitol Hill Wednesday for a Senate hearing examining whether COVID-19 mRNA injections carry plausible links to cancer, and why physicians who raised those concerns during the pandemic say they were silenced, smeared, and professionally punished for doing so.
The hearing before the Senate Permanent Subcommittee on Investigations, which Johnson chairs, featured testimony from oncologists, cardiologists, and clinical researchers who described findings of T-cell suppression, spike proteins in tumorous tissue, and mechanisms by which modified mRNA could potentially activate cancer-causing genes. It also featured witnesses who flatly denied any such connection exists.
What emerged was not a tidy consensus but a sharp, substantive clash, one that the federal health establishment spent years trying to prevent from happening in a public forum at all. That it finally took place in a Senate hearing room, with witnesses under oath, is itself a measure of how far the official COVID narrative has frayed.
Johnson set the table early. He noted that "the large percentage of the public remains unaware of the serious adverse events caused by COVID mRNA injections" and pointed to whistleblower testimony from April by Dr. Ana Szarfman, who said FDA officials relied on a flawed algorithm that "masked" extremely serious adverse events, including sudden death, within the Vaccine Adverse Events Reporting System.
The Wisconsin Republican also cited a figure of more than 39,000 deaths worldwide associated with the COVID injection.
Connecticut Democrat Richard Blumenthal, the subcommittee's ranking member, pushed back. He noted the National Cancer Institute had concluded "there is no evidence that COVID-19 vaccines cause cancer, lead to recurrence, or lead to disease progression."
That framing, official agency conclusion versus clinical observation and emerging research, defined the fault line for the rest of the afternoon.
Angus Dalgleish, professor emeritus of oncology at St. George's University of London, told the subcommittee he witnessed a sudden wave of cancer relapses in early 2022 among patients who had been stable for three to 18 years. The common factor: they had received the COVID-19 booster vaccine.
Dalgleish also reported that fellow physicians had seen a rise in aggressive, colorectal, and other cancers presenting in young demographics, patients in their 20s, 30s, and 40s.
Dr. Wafik El-Deiry, director of Brown University's Legorreta Cancer Center, said he had found nearly 70 publications documenting more than 300 reported cancer cases from 27 countries occurring after one or more vaccine doses, with cancers appearing near injection sites.
Dr. Saskia Mostert testified about her study finding that total excess deaths across 47 Western countries exceeded 3 million between January 1, 2020, and December 31, 2022.
The medical experts described evidence of T-cell suppression, spike proteins associated with tumorous tissues, and pathways by which the mRNA could insert into DNA and activate oncogenes, mutated genes that cause cancer, following vaccination.
A significant portion of the hearing challenged the public health establishment's early assurance that the vaccine would remain at the injection site and dissolve within 48 hours.
Dalgleish testified that the liposomal nanoparticles comprising the mRNA vaccine can insert themselves into the center of a cell's nucleus. His description was blunt:
"It is like herding cats, you cannot tell it where to go, where to insert."
Sabine Hazan, a doctor and CEO at ProgenaBiome, backed that assessment. "Nothing that you inject just stays in that area," she said. When Johnson asked whether the lipid nanoparticle was deliberately designed to permeate barriers, Hazan answered, "Yes."
Hazan also testified about her clinical research involving stool samples, which she said showed hydroxychloroquine and ivermectin helped treat COVID patients, with ivermectin increasing beneficial gut bacteria like bifidobacteria. She told the panel her peer-reviewed papers on those findings were repeatedly retracted in what she called "politically motivated retractions."
Her point landed with a single line:
"Remember if there was early treatment, vaccines would not have passed."
That statement goes to the heart of the incentive structure that governed the pandemic response. Under federal law, Emergency Use Authorization for vaccines required that no adequate, approved alternative treatment existed. If early treatments worked, the legal basis for the vaccine rollout would have been in jeopardy. Hazan's testimony suggests the retraction of her research was not merely academic disagreement but something with enormous financial and regulatory stakes.
The hearing was not one-sided. Dr. Julie Gralow, chief medical officer at the American Society of Clinical Oncology, testified that there was "no clinical evidence" of mRNA COVID-19 vaccines causing cancer.
"RNA breaks down quickly in the body and doesn't enter a person's DNA."
Gralow also cited a study at MD Anderson Cancer Center that found patients with non-small cell lung cancer who received the vaccine alongside immunotherapy had improved cancer outcomes compared to unvaccinated patients.
Cancer survivor Tamika Felder testified as well, warning that "misinformation and fearmongering about vaccines undermine trust, delay or prevent vaccination, and leave people vulnerable to preventable diseases." She specifically raised concerns about vaccine hesitancy around the HPV vaccine.
Johnson acknowledged the point directly. "We don't want to dispute the fact that vaccines can be helpful to save lives," he said. "I think our concern here is the denial of vaccine injuries."
The sharpest exchange came when Johnson pressed Gralow on the mechanics of the vaccine she had just defended.
Johnson stated that one of the "great lies told during COVID" was that the mRNA did not degrade, particularly because the COVID mRNA was not "normal" but "modified." He asked whether Gralow was aware that the modified mRNA was encapsulated in a lipid nanoparticle.
"I can't reliably comment," she responded.
Johnson did not let that pass. "So you're saying how safe and effective this is. But you don't know how it works," he said.
He then asked what "proof" would be needed before the public could be warned about possible dangers. Gralow suggested randomized clinical trials investigating whether COVID vaccines caused cancer, and acknowledged there could be "boundaries" on the extent of the vaccine's effects.
Johnson's reply framed the central dilemma:
"I'm trying to address the definitive proof. If that's what's required, we'll never warn the public about possible dangers."
Dr. Aseem Malhotra, a consultant cardiologist at HUM2N Clinic in London, supported that position. "When you make a diagnosis in medicine, you go on the strength of the evidence. It's very difficult to get complete and total proof," he said.
Malhotra's testimony carried personal weight. He told the panel he lost his 73-year-old father to sudden cardiac death after his father took two doses of a COVID vaccine. Malhotra himself was diagnosed with an autoimmune condition after being vaccinated.
He said he had been "smeared" and misrepresented in the media as opposing all vaccines, a characterization he rejected, after citing Dr. Dalgleish's work on the vaccine-cancer question.
His closing statement was the hearing's most forceful:
"The evidence presented here today exposes the corporate tyranny underlying public health practice. Tyranny emerges when people are afraid to say what they think. To save the health of the American people, and to save democracy, it is our responsibility to expose, resist, and dismantle the era of corporate tyranny we currently find ourselves in."
The hearing titled "Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications" did not produce a final verdict. That was never its purpose. What it did produce was a public, on-the-record confrontation between the official position, no evidence of harm, and a growing body of clinical observation and peer-reviewed research that says otherwise.
The FDA's reliance on a flawed VAERS algorithm, the retraction of peer-reviewed papers on early treatments, the rise of aggressive cancers in young patients, the 3 million excess deaths across 47 Western nations, the lipid nanoparticle's ability to cross biological barriers, none of these were addressed by the witnesses who defended the vaccines. They were simply set aside with the phrase "no clinical evidence."
For years, Americans were told to trust the science. What Johnson's hearing made clear is that the science was never settled, it was managed. Researchers who found inconvenient results had their papers pulled. Doctors who treated patients with off-label drugs were professionally targeted. The public was assured the vaccine stayed in the arm and dissolved. Witnesses testified under oath that this was false.
The question now is whether anyone in the federal health bureaucracy will be held accountable for what was suppressed, or whether "no clinical evidence" will remain the approved answer long after the evidence has piled too high to ignore.
When the standard of proof required to warn the public is set so high that it can never be met, the standard isn't protecting anyone. It's protecting the people who got it wrong.
